ScreenPoint Medical, a spin-off of Radboud university medical center, has raised 4.3 million euros from Siemens Healthineers and private investors. With these funds, the company can accelerate the market introduction of its learning computer program Transpara, which automatically interprets x-rays of breasts for possible tumors.
Radboud university medical center spin-off ScreenPoint Medical develops software applications that can detect breast cancer in early stages from x-rays of breasts (mammograms).
ScreenPoint’s product is called Transpara. It was developed based on artificial intelligence (AI) in combination with large image databases, and its aim is to facilitate and improve the interpreting of mammograms. The performance of the AI system can be compared to that of radiologists, and a recent study demonstrates that the detection performance of radiologists improves when they use Transpara. Use of the system could also help decrease radiologists’ workload.
Lack of radiologists
“Interpreting mammograms is one of the most challenging tasks in radiology”, says Nico Karssemeijer, CEO of ScreenPoint, “and a shortage of skilled radiologists exists in many regions around the world. While breast cancer incidence continues to rise, innovative artificial intelligence solutions are needed to ensure that the high quality of screening programs can be maintained.”
The investment of Siemens Healthineers marks the beginning of a strategic collaboration between the companies in the field of breast imaging and provides ScreenPoint with the opportunity to keep developing in the area of precision medicine. “We are very excited about the opportunity to partner with Siemens Healthineers. This partnership will enable an accelerated market introduction of Transpara.”
Nico Karssemeijer is member of theme Women's cancers.
Related news items
In order to maximize quality of life in pediatric psoriasis reaching for clear skin is necessary12 December 2019
In JAMA Dermatology, Bruins et al showed that greatest improvement in quality of life was achieved with 90% improvement of the Psoriasis Area and Severity Index (PASI) and 90% decrease of affected body surface area in a large cohort of children with psoriasis.read more
Bart-Jan Kullberg appointed as Chair of Health Council12 December 2019
As of 1 January 2020, Bart-Jan Kullberg has been appointed as the Chairperson of the Health Council of the Netherlands.read more
Jelle Barentsz's trilogy of educational papers in European Urology12 December 2019
Recently, a trilogy of educational papers by our full professor Jelle Barentsz has been published in European Urology. The publications address what urologists need to know about prostate-MRI.read more
ERC Consolidator Grant for Bousema and Sechopoulos12 December 2019
Teun Bousema and Ioannis Sechopoulos each receive an ERC Consolidator Grant of around two million euros. This European research subsidy will enable them to carry out research for the next five years.read more
Newly appointed Principal Clinicians RIHS 2020 - 20225 December 2019
These caregivers are at the forefront of renewing patient care and take the lead in the development and realization of the Radboud vision.read more